We invite you to learn more about LEQVIO at LEQVIOHCP.com. For US health care professionals (HCPs) only.
LEQVIO is a Novartis Pharmaceuticals Corporation brand and is not associated with any individual users on LinkedIn. To report side effects related to Novartis products please visit https://www.report.novartis.com/en, contact Novartis Pharmaceuticals Corporation at 1-888-669-6682 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
LEQVIO and the LEQVIO logo are registered trademarks of Novartis AG. Licensed from Alnylam Pharmaceuticals, Inc.
5/23 277879
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.leqviohcp.com
- Keywords
- Stratford Upon Avon.
Leqvio® (Inclisiran) Hcp Questions
Leqvio® (Inclisiran) Hcp's website is https://www.leqviohcp.com
Leqvio® (Inclisiran) Hcp's LinkedIn profile is https://www.linkedin.com/company/leqviohcp
Leqvio® (Inclisiran) Hcp's industry is
Pharmaceutical Manufacturing
Leqvio® (Inclisiran) Hcp's top competitors are
Repatha® (Evolocumab) Hcp,
Bristol Myers Squibb,
Vmed - Digital Agency,
Novartis,
Johnson & Johnson,
Pfizer,
Amgen,
Pcsk9 Education And Research Forum,
Iqvia,
Eli Lilly And Company.
Leqvio® (Inclisiran) Hcp's categories are Pharmaceutical Manufacturing
